Cachemia is a medical term that refers to a condition characterized by the abnormal presence of substances secreted by malignant tumors in the bloodstream. It is a rare complication associated with advanced stages of cancer and is particularly common among patients suffering from multiple myeloma, a type of cancer that affects plasma cells.
The term "cachemia" is derived from two words, "cache" which means "hidden or stored" and "emia" which refers to "a condition of the blood." This combination captures the essence of this condition, where harmful substances secreted by tumors are stored or hidden within the bloodstream.
Cachemia can cause a wide range of symptoms, including excessive fatigue, weight loss, weakness, loss of appetite, and general decline in overall well-being. The presence of these substances in the bloodstream can disrupt the normal function of various organs and systems, leading to further complications.
Treatment of cachemia primarily involves managing the underlying cancer and its symptoms. This can include various therapeutic approaches such as chemotherapy, radiation therapy, surgical intervention, or targeted therapies. Additionally, supportive care measures may be employed to alleviate the symptoms and improve the patient's quality of life.
Due to the complexity and often advanced stage of cancer associated with cachemia, the prognosis is often guarded. However, early detection and appropriate management can significantly improve outcomes and provide relief from the distressing symptoms experienced by patients.
